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Summary
A CD4+ T cell clone (A1.6) was derived from spleen cells of mice immunized with irradiated
sporozoites. This T cell clone recognizes an antigen that is shared by sporozoites and blood forms
ofPlasmodium berghei and differs from the circumsporozoite protein. Clone A1.6 displays cytotoxic
activity, produces IFN-,y and Ilr2 in vitro, and recognizes the plasmodial antigen in the context
of the class II I-Ed molecule. Passive transfer of this CD4+ clone into naive mice resulted in
a high degree of protection against sporozoite challenge.
P
rotective immunity against malaria sporozoites is medi-
ated, in part, by neutralizing antibodies that recognize
the repeat domain of the circumsporozoite (CS)t protein.
The protective role of these antibodies has been demonstrated
by the resistance to sporozoite challenge upon passive transfer
of anti-CS mAbs and also by the antibody-mediated protec-
tion induced by immunization with synthetic peptides (1).
T cell effector mechanisms, mediated by CD8+ cytotoxic
T cells, also play a major role in antisporozoite immunity,
as shown by the reversal of immunity obtained after in vivo
depletion of CD8+ T cells (2, 3). Furthermore, it has re-
cently been shown that passive transfer into naive mice of
CD8+ T cell clones, which recognize a defined epitope of
the CS protein, confers protection against sporozoite chal-
lenge (4).
While CD4+ T cells are known to play an important role
in the induction ofprotective antisporozoite antibodies, there
has up to now been no evidence indicating that theseT cells
may also inhibit the infectivity of sporozoites and/or the de-
velopment of liver stages.
Here we report some of the basic characteristics of a
CD4+ T cell clone we obtained from mice immunized with
irradiated sporozoites. This T cell clone recognizes an an-
tigen that is shared by sporozoites and blood forms of Plas-
modium berghei and differs from the CS protein. Passive transfer
of this CD4+ clone into naive mice protected most of these
animals against sporozoite challenge.
Abbreviations used in this paper. CS, circumsporozoite; FPLC, fine
performance liquidchromatography; NMS, normalmouse serum; NRBC,
normal red blood cells; NSG, noninfected mosquito salivary glands; PRBC,
parasitized red blood cells; SI, stimulation index.
Materials and Methods
Parasites, Mice, and Schedule of Immunization.
￿
Sporozoites and
blood stages of P. berghei (NK65 strain) were obtained as previ-
ously described (5). 6-wk-old female BALB/c mice (TheJackson
Laboratory, Bar Harbor, ME) were immunized intravenously with
105 irradiated sporozoites, twice a week, for 1 mo.
Antigens.
￿
Sporozoite extracts were prepared by sonicating these
parasites at a concentration of 10'/ml, in RPMI-1640 culture
medium, containing 10% FCS. The lysate was then centrifuged
at 10,000 g for 3 min, and the supernatant frozen at -20°C, until
used. P. bergheiparasitized red blood cells (PRBC) were obtained
from infected BALB/c mice and the erythrocytes lysed by saponin
treatment. After extensive washing, the blood stages were disrupted
by sonication and parasite extracts were prepared as described above.
Control extracts, prepared from an equivalent number of sonicated
noninfected mosquito salivary glands (NSG) and normal red blood
cells (NRBC), were processed similarly.
Fractionation ofthe PRBC Extract.
￿
The blood stageextract was
fractionated on a DEAE-5DW column (LKB Instruments Inc.,
Bromma, Sweden), using a fine performance liquid chromatography
(FPLC) apparatus (Pharmacia Fine Chemicals, Uppsala, Sweden),
according to a method previously described (6). All fractions
were dialyzed twice against PBS, aliquoted, and frozen at -20°C
until used.
Antibodies. Affinity-purified anti-L3T4 mAb (GK1.5), and
anti-class II mAbs of different specificities-namely, anti-I-A'
(MK-S4), anti-I-Ad (MK-D6), and anti-I-Ed (14-4-4S)-were
kindly provided by Dr. Jeanette Thorbecke, ofNew York University.
ProlferativeResponseofsplenicTCells.
￿
Immune spleen cells were
depleted of cell surface Ig+ cells, by adherence to anti-mouse Ig-
coated petri dishes, as described (7). An aliquot of 3 x 105 spleno-
cytesof this T cell-enriched fraction, was stimulatedwith different
amounts of PRBC extract, in RPMI-1640 medium, containing
0.5% normal mouse serum (NMS), and in the presence of irradi-
ated syngeneic APC (5 x 105). The proliferative response was
measured on day 5 by 'HTdR incorporation.
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T Cell Clone. Splenic T cells from sporozoite-immunized mice
were stimulated in vitro with a blood stage extract (2.5 x 106
PRBC/ml), in thepresence ofirradiated unprimed spleen cells, and
maintained for 1 wk in RPMI 1640 culture medium containing
0.5% NMS. They were then restimulated for 10 dwith a PRBC
extract, in RPMI 1640 medium containing 10% FCS and 10%
T cell growth factor (7), in the presence of irradiated syngeneic
APC. Tcell clones were derived from this bulk culture by limiting
dilution (7). Oneof theseclones, A1.6, was selected andexpanded
by weekly stimulation with a PRBC extract. The generation and
maintenance of an OVAspecific, BALB/c-derived, cytolytic CD4+
clone(5.9), whichwaskindly provided to us by Dr. CharlesJaneway
(Yale University, New Haven, CT), hasbeen earlier described (8).
Proliferative Response, IFN-y and 11,2 Production by the Cloned T
Cells. Two wk after antigen stimulation, 104cloned T cells were
restimulated by adding irradiated, antigen-pulsed, stimulator cells,
obtained by incubation of unprimed syngeneic spleen cells with
a blood stage extract. The supernatant fluids were removed, after
48 h of cultivation, and their concentrations of IFN-,y and IL-2
determined. While the IFN-y titer in the supernatants of stimu-
latedT cell clones was measured by an RIA (4), the IL2-depen-
dent cell line, CTLL2, was used to detect this lymphokine in the
T cell supernatants (9). The proliferative response was measured
on day 3 by the 'HTdR incorporation and expressed as stimula-
tion index (SI).
Cytolytic Assays.
￿
This assay was performed as described else-
where (10). Briefly, "Cr-labeled, BALB/c-derived, A20.2J cells,
kindly provided by Dr. Ralph Kubo (National Jewish Center,
Denver, CO), were pulsed with a PRBC extract (5 x 106
PRBC/ml) and then incubated with splenic T cells or the A1.6
T cells, at different E/T ratios, as indicated. After 12 h, the "Cr
releasefrom target cellswas measured andexpressedas the percent
of specific "Cr release.
Effect ofSelected mAbs on the Prolferative Response ofClone Al. 6.
The inhibitory effect ofanti-class II andanti-L3T4 antibodies on
the antigen-induced proliferation of T cell clone A1.6 was deter-
minedby adding thecorresponding mAbs to theculture, at a final
concentration of 0.5 FAg/ml (11).
Adoptive Transfer Experiments.
￿
Various numbersofcloned Tcells
or comparable numbers of normal splenocytes were injected intra-
venously into BALB/c mice. Immediately before transfer, the cells
were resuspended in serum-free culture medium (0.5 ml)containing
103 U of human rIL2. The mice were challenged, 4 h after the
cell transfer, by i.v. injection of sporozoites. A second dose of
103 U of rIL2 was administered intravenously, 20 h after
sporozoite challenge. Thin blood smears were prepared daily, be-
tween days 3 and 12 afterchallenge, stained with Giemsa, and ex-
amined by light microscopy to detect erythrocytic parasites. Pro-
tection was defined as the absence of parasitemia.
Results and Discussion
Initial experiments showed that splenic T cells from
sporozoite-immunized BALB/c mice were able to proliferate
and produce IFN-.y, upon in vitro stimulation with an ex-
tract ofbloodstages ofP. berghei (Fig. 1). Spleen cells of naive
mice were not stimulated by this blood stage extract. These
findings suggested that the observed activation of T cells of
sporozoite immunized mice was antigen specific, rather than
the result of mitogenic activity of the PRBC extract.
To furtheranalyze this phenomenon, aT cell clone, A1.6,
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Figure 1.
￿
Proliferative response of splenic T cells to extracts of P. ber-
ghei PRBC. Splenic T cells (3 x 105) from irradiated sporozoite-
immunizedmice were stimulated with an extract from different amounts
ofPRBC ("), or equivalent amounts of NRBC (O), in the presence of
syngeneic APC (5 x 105). Splenic T cells from naive mice were also
stimulated with the PRBC extract under identical conditions (A). The
proliferative response was measured on day 5 by the incorporation of
3HTdR.
was derived from the spleen cells of sporozoite-immunized
BALB/c mice. This clone (A1.6), which expresses the CD
4+8- phenotype, proliferates and produces IFN-y as well as
ILr2 upon incubation with antigen.
The pattern of reactivity of clone A1.6, cultured in the
presence of various antigen preparations, is summarized in
Table 1. We found that clone A1.6 displayeda strong prolifer-
Table 1.
￿
Specificity of the Proliferative Response and IFN-y
Production of CD4 + T Cell Clones to Antigen Stimulation
104 cloned T cells were cultured in the presence of 5 x 105 antigen-
pulsed APC. Extracts of PRBC and sporozoites were obtained from 5 x
106 parasites/ml. The NSGextract was derived from the same number
of noninfected mosquitoes as the sporozoites. The NRBC extract was
prepared from the same number of RBC as the PRBC. OVA was used
at a concentration of 100 Rg/ml.
t Thestimulation index (SI) wascalculated as the cpm .of cultures in the
presence of antigen, divided by the cpm in the absence of antigen.
S The concentration of IFN-y was determined in triplicate samples.
Clone Antigen" sit IFN-.YS
nglml
A1 .6 PRBC 70.4 102 ± 12
Sporozoites 3.3 2 ± 0.6
OVA 1.4 Neg
NRBC 1.1 Neg
NSG 0.8 Neg
- 1.0 Neg
5.9 PRBC 0.9 Neg
Sporozoites 1.0 Neg
OVA 37.2 64 ± 6
- 1.0 NegN
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Figure 2.
￿
Cytolytic assay of clone A1.6.
￿
Clone A1.6 was incubated
with 51Cr-labeled A20.2J cells, at the indicated E/T ratios, and pulsed
with a PRBC extract (") orjust incubated in medium (O). Supernatants
were removed 12 h later to assess the specific 51Cr release.
ative response and high levels of IFN-,y production when in-
cubated with an extract of P . berghei PRBC, and a more
modest, but clearly positive, response upon stimulation with
an extract prepared from a comparable number of sporozoites.
No activation was observed when NRBC, NSG, or OVA
was used as antigen.
In contrast, an OVA-specific, highly reactive CD4+ T cell
clone (5.9) did not proliferate nor produce IFN-,y when in-
cubated with a PRBC or sporozoite extract. These results
corroborated our earlier findings obtained with immune spleen
cells, indicating that the activation of A1.6 is plasmodial
specific.
The response of clone A1.6 to the sporozoite extract was
consistently much lower than that obtained with a PRBC
extract, suggesting that the corresponding antigen or epi-
tope is more abundant in blood stages. However, the corre-
sponding antigen (or epitope) is undoubtedly also present
in sporozoites. Besides, the T cell clone (A1.6) must have
been induced by a sporozoite and/or liver stage antigen, since
Figure 3.
￿
Incubation o£ antigen-induced A1.6proliferation by anti-class
II mAbs and anti-L3T4 mAb.
￿
Clone A1.6 (104 cells) was stimulated by
syngeneic APC (5 x 106), pulsed with 5 x 106 PRBC in the presence
of 0.5 Fig/ml ofanti-class II mAbs or anti-L3T4 mAb, and added to the
culture medium. The proliferative response was measured on day 3 of cul-
ture by the incorporation of 3HTdR. The data are expressed as cpm minus
background values.
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Figure 4.
￿
Fractionation ofPRBC extract byDEAE FPLC. An antigen
extract, corresponding to 2 x 109 PRBC, resuspended in 10 mM Tris
containing 10 mM NaCl at pH 8.4, wasloaded on a DEAF-5DW column.
After extensive washing with this buffer, the bound molecules wereeluted
by a 30-ml linear gradient, from 10 mM to 1 M NaCl, at a flow rate of
0.5 ml/min. The protein content of each fraction was monitored at 280
nm, and is represented by the solid line. The height of the bars Came-
sponds to the SI of clone A1.6 induced by the different fractions.
it was derived from mice immunized with irradiated
sporozoites, which invade hepatocytes, but are unable to trans-
form into blood stages (12).
An interesting finding was that clone A1.6 displayed cyto-
lytic activity upon stimulation with antigen. As shown in
Fig. 2, by a 51Cr release assay, this T cell clone lysed antigen-
pulsed A20.2J target cells, while, in the absence of antigen,
only minimal lytic activity was detected.
To identify the restrictive element involved in therecogni-
tion of this antigen, we analyzed the proliferative response
of clone A1.6 in the presence of several anti-class II mAbs
(Fig. 3). A mAb directed against I-Ed (14-4-4S) strongly in-
hibited this proliferative response, while antibodies directed
against I-Ad (MK-D6) and I-A' (MK-S4) had no significant
effect. As expected, GK1.5, a mAb reactive with the CD4
molecule, completely inhibited the proliferative response
of A1.6.
With the purpose ofcharacterizing the antigen recognized
by clone A1.6, the PRBC extract was fractionated by FPLC,
using a DEAF-5DW column. Fig. 4 shows the corresponding
elution profile, obtained by usinga linear NaCl gradient, and
the proliferative response induced by the corresponding FPLC
fractions, upon incubation with clone A1.6. Significant
proliferation of clone A1.6 was only induced by fractions 3-6,
fraction 4 inducing the strongest proliferative response.
We found that fraction 4 does not contain CS protein, as
determined by a two-site RIA, and also by Western blot anal-
ysis. Furthermore, clone A1.6 failed to be stimulated by a
recombinant P. berghei CS protein, and by overlapping syn-
thetic peptides, representing the repeat domain and theTable 2.
￿
Effect of Passively Transferred T Cell Clones on the Outcome of the Challenge of Mice with Di$erent Developmental Stages
BALB/c mice were injected intravenously with cloned T cells, normal spleen cells, or just RPMI medium; 107 cells were transferred in Exp. 1,
and 5 x 106 cells in Exps. 2 and 3.
t Mice challenged by the intravenous injection of 5 x 103 sporozoites.
S Challenged by the intravenous injection of 3 x 103 sporozoites.
11 Challenged with 103 blood forms of P. berghei.
flanking regions of this antigen (data not shown) . Taken to-
gether, these results indicate that an antigen which differs
from the CS protein is being recognized by this clone. We
are currently attempting to purify and further characterize
this antigen, using additional chromatographic techniques.
To determine whether clone A1.6 could protect against
sporozoite-induced malaria, these T cells were adoptively
transferred to naive BALB/c mice, which were challenged
4 h later, by the intravenous injection ofP berghei sporozoites.
We found that clone A1.6 consistently conferred a high de-
gree ofprotection to the recipient mice (Table 2) . No protec-
tion was observed in control groups receiving the same number
of normal spleen cells or of clone 5.9, an OVA-specific
CD4' T cell clone.
The protection conferred by A1.6 is stage specific sincemice
that received an identical number of these T cells were fully
susceptible to challenge with blood stages (103 PRBC) . Fur-
thermore, the prepatent period of these PR-BC-challenged
mice, their level of parasitemia, and their course of infection
was identical to that of controls.
This lack ofprotection against blood stage challenge may
be due to anumber of different causes, including differences
of susceptibility of the different developmental stages to cer-
tain lymphokines. In fact, while minute amounts of IFN-^y
We thank Dr. Victor Nussenzweig for reviewing the manuscript; Drs. Kyoko lida and Akira Ueda for
assistance with chromatographic procedures; and Ms. Rita Altszuler for her fine technical assistance.
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have a strong inhibitory effect on the liver stages of Plasmodia
(13), large amounts of this mediator inhibit only partially
the development ofblood stages (13-15). The cell type(s) in-
volved in the presentation of this plasmodial antigen as well
as the nature of the protective effect induced by the transfer
of these CD4+ T cells remains to be determined. It is con-
ceivable that these T cells recognize the processed antigen
on the surface ofKupffer cells, and secrete lymphokines which,
in turn, may have an inhibitory effect on the plasmodial in-
fected hepatocytes. It is also possible that these CD4+ cells
have a direct inhibitory effect on liverstages, afterrecognizing
the processed antigen on the surface of infected hepatocytes.
Since parenchymal liver cells havebeen shown to express class
11 MHC antigens after some viral infections (16), this ap-
pears to be a plausible working hypothesis.
In conclusion, the presentresults indicate that the effector
mechanisms ofantisporozoite immunity may include not only
neutralizing antibodies (1) and cytotoxic CD8+ T cells (4)
but also "protective" CD4+ T cells. Also important, from
the point of view of vaccine development, is the finding that
an antigen that differs from the CS protein and is shared by
sporozoites and blood stages may contribute to protection
against sporozoite challenge.
of P. berghei
Cells transferred' Challenge Mice infected/mice challenged
n/n
Mice infected
Exp . 1
A1 .6 Sporozoitest 1/5 20
Normal splenocytes Sporozoitest 5/5 100
None Sporozoitest 5/5 100
Exp. 2
A1 .6 Sporozoites$ 0/7 0
5.9 Sporozoitess 7/7 100
None Sporozoites§ 6/7 86
Exp. 3
A1 .6 Blood forms1l 5/5 100
Normal splenocytes Blood forms1l 5/5 100
None Blood forms1l 5/5 100This work was supportedby grant AI-27458-02 from the National Institutes of Health and grant DPE-
0453-A-00-5012-00 from the Agency of International Development. Dr. Fidel Zavala is a recipient of an
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